Human kinases and polynucleotides encoding the same

Details Human kinases and polynucleotides encoding the same Human kinases and polynucleotides encoding the same

2001-12-12

2003-06-17

Monshipouri, M. (Department: 1652)

Chemistry: molecular biology and microbiology

Micro-organism, per se ; compositions thereof; proces of...

Bacteria or actinomycetales; media therefor

C435S006120, C435S320100, C435S194000, C435S325000, C536S023200

Reexamination Certificate

active

06579710

ABSTRACT:

1. INTRODUCTION
The present invention relates to the discovery, identification, and characterization of novel human polynucleotides encoding proteins sharing sequence similarity with animal kinases. The invention encompasses the described polynucleotides, host cell expression systems, the encoded proteins, fusion proteins, polypeptides and peptides, antibodies to the encoded proteins and peptides, and genetically engineered animals that either lack or overexpress the disclosed genes, antagonists and agonists of the proteins, and other compounds that modulate the expression or activity of the proteins encoded by the disclosed genes, which can be used for diagnosis, drug screening, clinical trial monitoring, the treatment of diseases and disorders, and cosmetic or nutriceutical applications.
2. BACKGROUND OF THE INVENTION
Kinases mediate the phosphorylation of a wide variety of proteins and compounds in the cell. Along with phosphatases, kinases are involved in a range of regulatory pathways. Given the physiological importance of kinases, they have been subject to intense scrutiny and are proven drug targets.
3. SUMMARY OF THE INVENTION
The present invention relates to the discovery, identification, and characterization of nucleotides that encode novel human proteins and the corresponding amino acid sequences of these proteins. The novel human proteins (NHPs) described for the first time herein share structural similarity with animal kinases, including, but not limited to, serine-threonine kinases, casein kinases, calcium/calmodulin-dependent protein kinases, and mitogen activated kinases. Accordingly, the described NHPs encode novel kinases having homologues and orthologs across a range of phyla and species.
The novel human polynucleotides described herein, encode open reading frames (ORFs) encoding proteins of 870, 864, 764, 751, 654, 648, 548, 535, 895, 889, 789, 776, 982, 976, 876, 863, 957, 951, 851, and 838 amino acids in length (see respectively SEQ ID NOS: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, and 40).
The invention also encompasses agonists and antagonists of the described NHPs, including small molecules, large molecules, mutant NHPs, or portions thereof, that compete with native NHP, peptides, and antibodies, as well as nucleotide sequences that can be used to inhibit the expression of the described NHPs (e.g., antisense and ribozyme molecules, and open reading frame or regulatory sequence replacement constructs) or to enhance the expression of the described NHPs (e.g., expression constructs that place the described polynucleotide under the control of a strong promoter system), and transgenic animals that express a NHP sequence, or “knock-outs” (which can be conditional) that do not express a functional NHP. Knock-out mice can be produced in several ways, one of which involves the use of mouse embryonic stem cells (“ES cells”) lines that contain gene trap mutations in a murine homolog of at least one of the described NHPs. When the unique NHP sequences described in SEQ ID NOS:1-40 are “knocked-out” they provide a method of identifying phenotypic expression of the particular gene as well as a method of assigning function to previously unknown genes. In addition, animals in which the unique NHP sequences described in SEQ ID NOS:1-40 are “knocked-out” provide a unique source in which to elicit antibodies to homologous and orthologous proteins which would have been previously viewed by the immune system as “self” and therefore would have failed to elicit significant antibody responses. To these ends, gene trapped knockout ES cells have been generated in murine homologs of the described NHPs.
Additionally, the unique NHP sequences described in SEQ ID NOS:1-40 are useful for the identification of protein coding sequence and mapping a unique gene to a particular chromosome. These sequences identify actual, biologically verified, and therefore relevant, exon splice junctions as opposed to those that may have been bioinformatically predicted from genomic sequence alone. The sequences of the present invention are also useful as additional DNA markers for restriction fragment length polymorphism (RFLP) analysis, and in forensic biology.
Further, the present invention also relates to processes for identifying compounds that modulate, i.e., act as agonists or antagonists, of NHP expression and/or NHP activity that utilize purified preparations of the described NHPs and/or NHP product, or cells expressing the same. Such compounds can be used as therapeutic agents for the treatment of any of a wide variety of symptoms associated with biological disorders or imbalances.
4. DESCRIPTION OF THE SEQUENCE LISTING AND FIGURES
The Sequence Listing provides the sequence of the novel human ORFs encoding the described novel human kinase proteins.


REFERENCES:
patent: WO00/73469 (2000-12-01), None
Database EBI ‘Online’ EMBL, Hinxton, Cambridgeshire, UK; May 10, 2001, Ohara et al., “Homo sapiens mRNA for KIAA1855 protein, partial cds.” Database accession No. AB058758, XP002211382, abstract.
Database EBI ‘Online’ EMBL, Hinxton, Cambridgeshire, UK; Sep. 29, 2000, Sugano et al., “Homo sapiens cDNA: FLJ22032 is, clone HEP08743,” Database accession No. AK025685, XP002211383, abstract.
Database EBI ‘Online’, EMBL, Hinxton, Cambridgeshire, UK, Mar. 23, 2000, Birren et al., “Homo sapiens clone RP11-117C11, working draft sequence, 36 unordered pieces,” Database accession No. AC026532, XP002211384, abstract.
Database EBI ‘Online’, EMBL, Hinxton, Cambridgeshire, UK, Dec. 8, 1999, Skuce, C., “Human DNA sequence from clone RP3-330M21 on chromosome 6,” Database accession No. AL133375, XP002211385, abstract.
Hanks, S.K., et al., “The Protein Kinase Catalytic Domain Sequence Database: Identification of Conserved Features of Primary Structure and Classification of Family Members,” Melk-Systeme Bou-Matic, Oldenburg, DE, vol. 200, 1991, pp. 38-62, XP000563379.
Hanks, S.K., et al., “The Protein Kinase Family: Conserved Features and Deduced Phylogeny of the Catalytic Domains,” Science, American Association for the Advancement of Science, U.S., vol. 241, No. 4861, Jul. 1, 1988, pp. 42-52, XP000613735, ISSN: 0036-8075.
Hanks, S.K., et al. “The Eukaryotic Protein Kinase Superfamily: Kinase (Catalytic) Domain Structure and Classification,” FASEB Journal, Fed. of American Soc. for Experimental Biology, Bethesda, MD, US, No. 9, May 1995, pp. 576-596, XP001078836, ISSN: 0892-6638.
Hanks, S.K., et al., “Use of degenerate oligonucleotide probes to identify clones that encode protein kinases,” Methods in Enzymology, US, vol. 200, 1991, pp. 525-532, XP001096015, ISSN: 0076-6879.
International Search Report, International Application No. PCT/US01/49068, Dec. 12, 2001 (Attorney Docket No. LEX-0281-PCT).

Affiliated with

Also associated with

Rating

Human kinases and polynucleotides encoding the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human kinases and polynucleotides encoding the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human kinases and polynucleotides encoding the same will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3132126